Indolent Lymphoma
Drug | Drug Name | Drug Description |
---|---|---|
DB00291 | Chlorambucil | A chemotherapy agent used in the management of chronic lymphocytic leukemia and malignant lymphomas. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00291 | Chlorambucil | DNA | target |
DB00291 | Chlorambucil | Glutathione S-transferase P | enzyme |
DB00291 | Chlorambucil | Solute carrier organic anion transporter family member 1A2 | transporter |
DB00291 | Chlorambucil | Glutathione S-transferases (Cytosolic) | enzyme |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB12483 | Copanlisib | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB00073 | Rituximab | 1 | Active Not Recruiting | 1 |
DB17224 | STRO-001 | 1 | Active Not Recruiting | 1 |
DB11850 | Ublituximab | 1 | Active Not Recruiting | 1 |
DB00441 | Gemcitabine | 1 / 2 | Terminated | 1 |
DB00526 | Oxaliplatin | 1 / 2 | Terminated | 1 |
DB00073 | Rituximab | 1 / 2 | Terminated | 1 |
DB00188 | Bortezomib | 2 | Completed | 1 |
DB00242 | Cladribine | 2 | Completed | 1 |
DB09054 | Idelalisib | 2 | Active Not Recruiting | 1 |
DB09027 | Ledipasvir | 2 | Unknown Status | 1 |
DB11697 | Pacritinib | 2 | Completed | 1 |
DB00073 | Rituximab | 2 | Completed | 1 |
DB08934 | Sofosbuvir | 2 | Unknown Status | 1 |